Updated 2 October 2026 · Aurelis Peptides
KPV is a very short peptide made from three amino acids. Its main research interest is inflammation, especially in gut-related models. Researchers have investigated how it enters cells and how those cells respond.
The findings below come from laboratory cells and mouse experiments.
| Main interest | Gut-related inflammation |
|---|---|
| What studies looked at | Inflammatory activity in cells and mouse models |
| Study context | Laboratory and animal research |
| Listed content | 10 mg per unit |
What did the inflammation studies find?
- KPV reduced activity in inflammatory pathways in the studied cells.
- Those cells released fewer inflammatory messenger substances.
- The research also investigated mouse models of gut inflammation.
The primary study linked these results with a peptide-transport system that carries KPV into cells. Read the gut-inflammation study.
Why delivery research is part of the story
A separate mouse study investigated KPV in a specially designed carrier and gel. The complete delivery system was part of the experiment. This adds a formulation topic to the research, alongside the peptide’s inflammatory findings. Read the delivery study.
For product enquiries, tell the team whether you are asking about the individual peptide or a finished presentation.
KPV in the Aurelis collection
Aurelis lists KPV 10 mg. KPV is also named in the KLOW source formulation. KLOW’s full composition needs confirmation because its component amounts and total do not reconcile. The blend guide records that detail.
Explore KPV with Aurelis
Explore KPV 10 mg or ask about a listed combination. Our team can confirm the product details, local availability and available batch records.
Aurelis holds stock in Australia, Canada and the USA. Tell us your destination so our team can check local availability.
Enquire about KPV · Open the KPV catalogue profile